Shopping Cart

Axcella Health Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

SKU
GDPH500584D
READ MORE
USD 250
Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750
Axcella Health Inc (Axcella), formerly Pronutria Biosciences Inc is a developer of transformative medicines. The company's lead clinical-stage candidates are based on cell-specific sets of amino acids that regulate multiple biological pathways. Its amino acid therapies focus on treating orphan diseases in muscle, neurological, metabolic and liver settings which include myotonic dystrophy, intractable epilepsy syndromes, pediatric nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, sarcopenia and other disease populations. Axcella has set up a proprietary platform to identify the amino acid profile associated with a medical condition and de-risk the clinical development process. Axcella is headquartered in Cambridge, Massachusetts, the US.
READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Summary

Axcella Health Inc (Axcella), formerly Pronutria Biosciences Inc is a developer of transformative medicines. The company's lead clinical-stage candidates are based on cell-specific sets of amino acids that regulate multiple biological pathways. Its amino acid therapies focus on treating orphan diseases in muscle, neurological, metabolic and liver settings which include myotonic dystrophy, intractable epilepsy syndromes, pediatric nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, sarcopenia and other disease populations. Axcella has set up a proprietary platform to identify the amino acid profile associated with a medical condition and de-risk the clinical development process. Axcella is headquartered in Cambridge, Massachusetts, the US.

Axcella Health Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Axcella Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Axcella Health Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Pronutria Raises USD39 Million in Series C Financing 10

Pronutria Raises USD28.3 Million in Venture Financing 10

Pronutria Raises USD12.3 Million In Series B Financing 11

Axcella Health (Pronutria Biosciences) Secures USD12.25 Million in Series B Funding Round 12

Pronutria Raises USD10.8 Million In Series A Financing 13

Partnerships 14

KineMed Enters into R&D Agreement with Pronutria Biosciences 14

Equity Offering 14

Pronutria Biosciences Raises USD42.5 Million in Equity Investment 14

Axcella Health Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

Corporate Communications 19

Jun 14, 2017: Axcella Appoints Tony Tramontin, Ph.D., as Senior Vice President, Chief Scientific Officer 19

May 11, 2017: Axcella Announces the Appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., as Executive Vice President, Chief Strategy and Corporate Development Officer 20

Jan 03, 2017: Axcella Augments Leadership Team with the Appointment of Three Key Hires 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Axcella Health Inc, Pharmaceuticals & Healthcare, Key Facts 1

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Axcella Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Axcella Health Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Axcella Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Pronutria Raises USD39 Million in Series C Financing 10

Pronutria Raises USD28.3 Million in Venture Financing 10

Pronutria Raises USD12.3 Million In Series B Financing 11

Axcella Health (Pronutria Biosciences) Secures USD12.25 Million in Series B Funding Round 12

Pronutria Raises USD10.8 Million In Series A Financing 13

KineMed Enters into R&D Agreement with Pronutria Biosciences 14

Pronutria Biosciences Raises USD42.5 Million in Equity Investment 14

Axcella Health Inc, Key Competitors 16

Axcella Health Inc, Key Employees 17

To know more information on Purchase by Section, please send a mail to

Products

Axcella Health Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.